baber/WOPTO huggingface dataset:
Patent NZ-548758-A (NZ)
Title: Security verification system III
Inventor: HURSTON RYAN
Filed: 2006-07-26
Abstract: A method of determining the accuracy of securities registered on a vehicle comprises receiving an electronic file of search records. The search records are generated by and received from a government registry of registered securities, each search record relating to a registered security on the government registry. The registered security relates to a vehicle. The electronic file of search records is then sent to a data source. Some portion of each search record contents is for use as a key to obtain vehicle information from the data source. An electronic file containing a plurality of results records is received from the data source. A result record contains vehicle information that relates to the key contained in an associated search record, for one or more result records. Some portion of the vehicle information contained within the result record with some portion of the corresponding search record is compared to identify discrepancies between the result and search records. If a discrepancy is identified, a report that contains some portion of the result of the comparison is formed and sent to one or more parties who are interested in the registered security relating to the search record.
Patent NZ-553147-A (NZ)
Title: Improved process for the preparation of oxidized phospholipids
Inventor: HALPERIN GIDEON
IPC: C07F9/02
Filed: 2005-07-10
Abstract: Disclosed is a method of preparing a compound having a glycerolic backbone and at least one oxidized moiety-containing residue attached to the sn-2 position of the glycerolic backbone via an ether bond, the compound having the general Formula II, wherein A1 is CH2, CH=CH, or C=O, A2 is CH2, R1 is alkyl, R2 is as pictured, and wherein the rest of the substituents are as disclosed in the specification, the method comprising: Providing a first compound of formula I, wherein the substituents are as defined in the specification and reacting the compound and processing the products as described in the specification.
Patent NZ-555248-A (NZ)
Title: Apparatus and system having dry gene silencing compositions
Inventor: ROBERTSON BARBARA
IPC: C07H21/02
Filed: 2005-11-21
Abstract: Provided is a reverse transfection apparatus for introducing siRNA into a cell to effect gene silencing, the apparatus comprising: a well plate having a well configured for transfecting cells, wherein the well is substantially devoid of a polynucleotide carrier such that the well plate is storable in a sealed, sterile package for an extended period of time at a temperature of up to at least 37°C while maintaining functionality of an siRNA deposited therein; and a ribonucleic gene silencing composition deposited in the well, the gene silencing composition having at least two different siRNAs capable of silencing a first target gene, characterised in that the ribonucleic acid siRNA gene silencing composition is substantially dry and substantially devoid of a polynucleotide carrier such that the at least two siRNAs are capable of being solubilized or suspended in an aqueous medium in an amount sufficient for transfecting cells in the well.
Patent NZ-563003-A (NZ)
Title: Use of a farnesyl transferase inhibitor to enhance autophagic protein degradation in protein conformation disorders
Inventor: KAUSHAL SHALESH
IPC: A01N43/62
Filed: 2006-04-27
Abstract: The use of a farnesyl transferase inhibitor, FTI-277 to enhance autophagic protein degradation for the treatment or prevention of a protein conformation disorder (PCD) selected from the group consisting of alpha1-antitrypsin deficiency, Huntington's disease, nephrogenic diabetes insipidus, Jacob-Creutzfeld disease, glaucoma (excluding neo-vascular glaucoma), corneal dystrophies, retinoschises, Stragardt's disease autosomal dominant druzen and Best's macular dystrophy. The treatment can further comprise the use of 11-cis-retinal, 9-cis-retinal or a 7-ring locked isomer of 11-cis-retinal for treating an ocular PCD. In particular the farnesyl transferase inhibitor or FTI-277 inhibits the protein mammalian target of rapamycin (mTOR) or the protein Ras homolog enriched in brain (Rheb).
Patent NZ-566005-A (NZ)
Title: 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrido[1,2-a]azepine compounds useful as glucocorticoid receptor modulators
Inventor: PLATE RALF
IPC: A61K31/55
Filed: 2006-08-25
Abstract: Disclosed are compounds of formula (I), wherein the substituents are as defined in the specification. The compounds are highly specific for the glucocorticoid receptor and may be used for treating inflammatory diseases.
Patent NZ-567277-A (NZ)
Title: Use of neuronal sodium channel antagonists for the control of ectoparasites in homeothermic animals
Inventor: HEANEY KATHLEEN
IPC: A01N25/02
Filed: 2003-10-17
Abstract: Use of a neuronal sodium channel antagonist of formula (Ia) or a stereoisomer thereof, and fipronil in the manufacture of a medicament for the prevention, amelioration or control of ectoparasitic infection or infestation in a homoeothermic animal.
Patent NZ-569164-A (NZ)
Title: Modularly contained dual or multiple sysem water heating element assembly
Inventor: STEENEKAMP RAOUL
IPC: F24H1/20
Filed: 2006-03-06
Abstract: A modular water heating assembly containing two heating elements (1, 2), each having a thermostat module (5, 6) inserted into a sensing tube (3, 4) and attached to the same threaded boss (7). The heating elements are thus contained in a single assembly with the elements having a fixed temperature set point differential such that the elements are switched on or off to maintain a constant temperature and reduce energy consumption by minimizing temperature overshoot.
Patent NZ-569899-A (NZ)
Title: Azaindoles useful as inhibitors of janus kinases
Inventor: FARMER LUC
IPC: A61K31/506
Filed: 2007-01-17
Abstract: Disclosed are azaindole compounds represented by general formula (I), or pharmaceutically acceptable salts thereof, wherein R1 is N(R")-CR8R9-C(O)-NR14R7 and the other substituents are disclosed within the specification. Also disclosed is the use of the azaindole compounds of formula (I) in the manufacture of a medicament for inhibiting JAK kinase activity or treating or lessening the severity of a proliferative disorder, a cardiac disorder, a neurodegenerative disorder, an autoimmune disorder, a condition associated with organ transplantation, an inflammatory disorder, or an immunologically mediated disorder.
Patent NZ-570764-A (NZ)
Title: 8-Azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
Inventor: LONG DANIEL
IPC: A61P1/10
Filed: 2007-02-28
Abstract: Disclosed is a 8-azabicyclo[3.2.1]oct-3-yl)-benzamide of formula (I): wherein: R1, R2 and R3 are defined in the specification, A and G are alkylenyl or a pharmaceutically-acceptable salt or solvate thereof. Also disclosed is the use of said compound for manufacture of a medicament for the treatment of a disease or medical condition in a mammal associated with mu opioid receptor activity, wherein the disease or condition is opioid-induced bowel dysfunction or post-operative ileus and a process to prepare said compound.
Patent NZ-573024-A (NZ)
Title: A movement simulation means, which uses rollers to turn the wheel of a stationary stroller
Inventor: DALTON AARON
IPC: B62B9/22
Filed: 2008-11-24
Abstract: Movement simulation means (1) and their use is disclosed. The movement simulation means (1) comprises a roller (2) and drive means to spin the roller. The roller can receive a wheel of a stroller and spin so that the wheel turns. The turning of the wheel simulates forward and/or backward movement of the stroller. The roller has a wheel receiving portion in a central part (5) of the roller, which is of lesser cross section than the adjacent parts (4) of the roller. When the wheel is in the wheel receiving portion (5), it is prevented from moving laterally out of the recess due to gravity.
Patent NZ-579504-A (NZ)
Title: Tie for identification rings comprising cleavable region on the strap
Inventor: GELIBERT STEPHANE
IPC: A01K11/00
Filed: 2008-02-07
Abstract: A tie that can be used to create an identification ring for an animal is disclosed. The tie comprises a strap (1) having two end parts (1A, 1B) provided with a female part and a male part, respectively. The female part is an opening (2) in the strap (1) which is bordered by a cleavable area (2A-2C) of the strap. When this strap (1) is used to create an identification ring for an animal, the diameter of the ring can be increased without removing the ring from the animal.
Patent NZ-581128-A (NZ)
Title: Lamp with a compound parabolic reflector
Inventor: WILCOX KURT S
IPC: F21W131/105
Filed: 2007-05-23
Abstract: A luminaire for illuminating a target zone having plural subregions in front of and to the sides of the luminaire comprises housing 17 with wall, a lamp holder and a reflector. The walls 25, 27 of the housing 17 define a bottom opening 33, with the opening 33 defining a plane. The lamp holder in the housing 17 is positioned to support an electric lamp 19 that is axially oriented generally perpendicular to the plane of the opening. The lamp 19 has a light source that is substantially parallel to the axis of the electric lamp 19 and has plural source sectors. The plural source-sectors are a three-dimensional spaces occupied by a light-emitting segment. The reflector in the housing 17 partially surrounds the lamp 19 and its light source. The reflector has a segmented centre portion and a pair of segmented side portions 61, 63. The segmented center portion has first and second side edges each forming sides of the bottom opening and a first plurality of center segments each of which is parabolic in a cross-section. The parabolic cross-sections of the segments have focal points in different ones of the plural light source-sectors such that each segment directs a preponderance of its reflected light toward a particular target zone subregion in front of the luminaire. Each side portion 61, 63 forms a side of the bottom opening and is joined to the center portion along a respective one of the side edges. Each side portion has a plurality of side segments 10, 103, 107, 109, 111, 113, 115 each of which is parabolic in a cross-section, with the cross-sections of the segments having focal points along the light source-sectors such that each segment directs a preponderance of its reflected light toward a particular target zone subregion to a respective side of the luminaire.
Patent NZ-584019-A (NZ)
Title: Method of preparing water-soluble cellulose hydrolysis products using ionic liquids
Inventor: FANSELOW MARKUS
IPC: C08J3/09
Filed: 2008-09-03
Abstract: Disclosed is a process for the preparation of water-soluble cellulose hydrolysis products, said process comprises admixing cellulose with an ionic liquid capable of solvating or dissolving at least some of the cellulose; and treating the resulting solvate or solution with an acid in the presence of water, said acid having a pKa in water of less than 2 at 25°C; said ionic liquid being a compound comprised solely of cations and anions and which exists in a liquid state at a temperature at or below 150°C, and in which the anions are selected from sulfate, hydrogen sulphate and nitrate, and the cation of the ionic liquid is preferably selected from pyridinium, pyridazinium, pyrimidinium, pyrazinium, imidazolium, pyrazolium, oxazolium, triazolium, thiazolium, piperidinium, pyrrolidinium, quinolinium or isoquinolinium; said acid is preferably selected from trifluoroacetic acid, p-toluene sulphonic acid, trifluoromethane sulfonic acid, trichloromethane sulfonic acid, hydrochloric acid, hydrobromic acid, hydriodic acid, tetrafluoroboric acid, or sulfuric acid.
Patent NZ-587269-A (NZ)
Title: Windscreen wipers arranged at opposite corners of the window to be wiped, each wiping one quadrant
Inventor: MULLER CONRAD
IPC: B60S1/46
Filed: 2010-08-09
Abstract: A windscreen wiper system for a vehicle cabin is disclosed. The system is suitable for the vehicle cabin of a straddle carrier. The windscreen has a largely rectangular surface area with a wiper drive motors (4) disposed at two diagonally opposite corners of the windscreen. Each motor has a wiper arm (2), a joint (5) and a blade (3) to clean the window. The motion of the blade (3) is from a position largely parallel to one side of the windscreen to be wiped to largely parallel to the other side. Various positions and arrangements for nozzles (6) are also disclosed, on the cabin or wiper arm (2).
Patent NZ-593846-A (NZ)
Title: Method and system for producing hydrocarbons from a hydrate reservoir using available waste heat
Inventor: BALCZEWSKI JOHN T
IPC: E21B43/14
Filed: 2009-12-28
Abstract: 614230 A method and system of producing hydrocarbons from a hydrocarbon containing subterranean hydrate reservoir is disclosed. Waste heat is captured and transferred to a fluid to create a heated fluid, which is provided by injector wells (34) to a hydrocarbon bearing hydrate formation (22) to dissociate hydrates into natural gas and water. The natural gas and water are released into an hour glass shaped dissociation zone (26) formed between the hydrate formation and a producer well (34). The dissociated natural gas and water is transported via the producer well to a production facility (40). The waste heat can be heat generated from surface facilities such as a Gas To Liquids (GTL) plant, a Liquefied Natural Gas (LNG) plant, an electric or power generation plant, and an onshore or offshore facility producing other conventional or unconventional hydrocarbons from a subterranean reservoir. Alternatively, the waste heat can be obtained from subterranean reservoirs such as hydrocarbon containing producing wells and geothermal wells producing heated water.
Patent NZ-594522-A (NZ)
Title: Manipulation of organic acid biosynthesis and secretion with cirate synthase
Inventor: SPANGENBERG GERMAN
IPC: C12Q1/68
Filed: 2004-04-14
Abstract: Disclosed is a substantially purified or isolated nucleic acid or nucleic acid fragment encoding citrate synthase (CS), or complementary or antisense to a sequence encoding CS, and including a nucleotide sequence selected from the group consisting of (a) sequences shown in Figures 4 and 6 hereto (SEQ ID NOS 11 and 13 to 16 respectively); (b) complements of the sequences recited in (a); (c) sequences antisense to the sequences recited in (a) and (b); (d) functionally active fragments and variants having at least approximately 90% identity to the functional part of the sequences recited in (a), (b) and (c) and having a size of at least 30 nucleotides; and (e) RNA sequences corresponding to the sequences recited in (a), (b), (c) and (d). Further disclosed is a substantially purified or isolated CS polypeptide from a Lolium species including an amino acid sequence selected from the group consisting of (a) sequence shown in Figure 5 hereto (SEQ ID NO 12); (b) functionally active variants thereof having at least approximately 95% identity to the sequence recited in (a); and (c) functionally active fragments or variants of the sequences recited in (a) from a Lolium species.
Patent NZ-597822-A (NZ)
Title: Solutions comprising polyethylene glycol and electrolytes
Inventor: MORRISSEY FRANCES
IPC: A61K9/00
Filed: 2010-07-30
Abstract: 597822 Disclosed herein is a solution in water comprising the following components: (a) N x (70 to 130) g/L polyethylene glycol (PEG) having an average molecular weight of 2500 to 4500; (b) N x (1.6 to 4.0) g/L sodium chloride; (c) N x (0.2 to 0.6) g/L potassium chloride; (d) N x (0.6 to 2.2) g/L sodium bicarbonate; (e) preservative, such as methyl paraben, ethyl paraben or benzyl alcohol. Additionally disclosed is a solution further comprising the following components: (f) optionally N x an amount of flavouring; and (g) optionally N x an amount of sweetener where N is in the range of 2 to 8. The solution is a concentrate for dilution. In use it is diluted N-fold with water to provide a solution for administration to a subject for the treatment of constipation or faecal impaction. Also provided are solutions, kits, unit doses and methods that comprise or use the solutions.
Patent NZ-603075-A (NZ)
Title: Method for treating wastewater
Inventor: LIU CHANGLIN
IPC: C02F1/02
Filed: 2012-10-17
Abstract: Disclosed herein is a method for treating wastewater, the wastewater being produced by roasting a starting material in the presence of a sodium salt, leaching soluble sodium vanadate, and precipitating ammonium polyvanadate from an acidic leaching solution with an ammonium salt, the method comprising steps of: a) concentrating the wastewater having a pH value of 5.0~6.5 at a temperature of 90 degree C or higher to crystallize anhydrous sodium sulfate from the wastewater to obtain a first crystal suspension, and separating the anhydrous sodium sulfate from the first crystal suspension at a temperature of 90 degree C or higher to obtain a first solution; b) crystallizing a double salt of sodium sulfate and ammonium sulfate from the first solution at a temperature of 9~20 degree C, and separating the double salt to obtain a second solution; and c) concentrating the second solution by evaporation at a temperature of 70 degree C or higher, crystallising mixed ammonium salts including ammonium sulfate and ammonium chloride from the second solution at a temperature of 60~65 degree C to obtain a second crystal magma, and separating the mixed ammonium salts from the second crystal suspension at a temperature of 55 degree C or higher to obtain a third solution. Preferably wherein: a ratio of a volume of the wastewater before the concentrating in the step a) to a volume of the first crystal magma is 10:3~10:1, and a time during which the anhydrous sodium sulfate is crystallized is at least 40 minutes. the crystallizing in the step b) comprises crystallising the double salt of sodium sulfate and ammonium sulfate from the first solution at a temperature of 9~14 degree C for at least 3 hours. in the step c), a ratio of a volume of the second solution to a volume of the second crystal magma is 2~2.5:1, and a time during which the mixed ammonium salts are crystallized is at least 2 hours.
Patent NZ-603343-A (NZ)
Title: Macrocyclic indole derivatives useful as hepatitis C virus inhibitors
Inventor: VENDEVILLE SANDRINE MARIE HELENE
IPC: A61K31/55
Filed: 2009-07-08
Abstract: ABSTRACT - 603343 The disclosure relates to a indolo[2,1-a][2]benzazepine derivative compound having the structural formula shown herein, including stereochemically isomeric forms, and N-oxides, salts, hydrates, and solvates thereof, wherein the variables are defined in the specification for treating hepatitis C virus.
Patent NZ-607264-A (NZ)
Title: A structure and method of construction
Inventor: PETERKEN NEIL TERRY
IPC: E03B11/00
Filed: 2012-02-15
Abstract: A portable water tank with a liner that extends over the top edge of a tank shell. A clamp secures the liner in a channel in the top edge. An edge of the liner extends over the top edge of the tank shell so as to lie over the channel. A clamp mounting is fixed with respect to the tank shell at a position outside of the tank shell. A clamp member is moveably engageable with the clamp mounting. The clamp member moves with respect to the clamp mounting towards the channel to force the liner into the channel and thereby secure the liner to the tank shell.
Patent NZ-612732-A (NZ)
Title: Hop oxidation-reaction product, preparing method thereof and use thereof
Inventor: MANABE FUMITOSHI
IPC: A61P3/06
Filed: 2011-12-15
Abstract: Disclosed is a use of a hop oxidation-reaction product or an extract thereof in the manufacture of a composition for use in suppressing fat accumulation and/or weight gain, wherein a proportion of a peak area of iso alpha acid, alpha acid and β acid to a total peak area as determined by HPLC analysis of the hop oxidation-reaction product is 20% or less.
Patent NZ-613100-A (NZ)
Title: An electric fence connector
Inventor: PEARCE GRANT
IPC: A01K3/00
Filed: 2012-06-13
Abstract: Disclosed is an electric fence connector (1). The connector includes an elongate body (2) having live engagement means (15) one end and a live barrier attachment means (13) at the other end. The live engagement means and live barrier attachment means are conductively connected. The maximum lateral dimension of the connector is less than 42mm, allowing passage through an aperture, such as a pigtail, of an electric fence standard. The connector may further have an isolated engagement means (10) at the one end, which is electrically isolated from the live engagement means and the live barrier attachment means. The connector may further comprise an isolated barrier attachment means. The maximum lateral dimension may be less than 40mm or 35mm. The barrier attachment may be formed by three or more apertures or slots (7, 8, 16) in the body of the connector. The handle is produced by injection moulding over the conductive element (12) joining the live engagement means to the live barrier engagement means.
Patent NZ-613302-A (NZ)
Title: Canopy
Inventor: TOYE JONATHAN DALLAS
IPC: E04H15/16
Filed: 2012-07-16
Abstract: 613302 A canopy has sheet material of rectangular form with vent cover formed from strip folded about a longitudinal line and vent aperture on inside of strip and sheet material of canopy and outer side of strip forming vent cover.
Patent NZ-619625-A (NZ)
Title: Saponin-containing, beer-taste beverages
Inventor: TERANISHI TAKESHI
IPC: C12G3/02
Filed: 2012-08-27
Abstract: The disclosure relates to a beer-taste beverage comprising a saponin and a caramel colorant wherein the saponin content is at least 1 mg/L but not greater than 50 mg/L. The saponin may be quillaja saponin. The beverage may be non-alcoholic and not use malt as an ingredient. The disclosure also relates to a method of whitening the foam of a colorant-containing, beer-taste beverage, which comprises incorporating a saponin in the beverage.
Patent NZ-624644-A (NZ)
Title: An aerosol generating device with adjustable airflow
Inventor: DUBIEF FLAVIEN
IPC: A24F40/485
Filed: 2012-12-05
Abstract: A method for varying air flow speed in an aerosol generating system comprising an aerosol generating device in cooperation with a cartridge. The aerosol generating system comprises a vaporizer 119 for heating an aerosol-forming substrate 115 to form an aerosol, at least one air inlet 123 defined between the cartridge and the aerosol generating device, and at least one air outlet 125. The air inlet 123 and the air outlet 125 are arranged to define an air flow route between the air inlet 123 and the air outlet 125. The method comprises moving a first member of the cartridge linearly relative to a second member of the aerosol generating device to adjust the size of the at least one air inlet 123, so as to vary the air flow speed in the air flow route..
Patent NZ-627096-A (NZ)
Title: Triazinyl compounds and their methods of use
Inventor: CIANCHETTA GIOVANNI
IPC: C07D251/26
Filed: 2013-01-05
Abstract: Disclosed are triazine compounds of formula (I), wherein the substituents are as defined in the specification. The disclosed compounds are useful for cancer characterized by the presence of an IDH2 mutation, wherein the IDH2 mutation results in a new ability of the enzyme to catalyze the NAPH-dependent reduction of α-ketoglutarate to R(-)-2-hydroxyglutarate in a patient. Examples of compounds of formula (I) are: 2-(3-(4-(isopropylamino)-6-phenyl-1,3,5-triazin-2-yl-amino)phenyl)acetonitrile 3-[4-isopropylamino-6-(pyridin-4-ylamino)-[1,3,5]triazin-2-yl]-phenol
Patent NZ-705994-A (NZ)
Title: Process for preparing pemetrexed di potassium and its hydrates
Inventor: SHRAWAT VIMAL KUMAR
IPC: C07D487/04
Filed: 2013-10-16
Abstract: The present invention relates to Di potassium (S)-2-(4-(2-(2-amino-4-oxo4,7,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzamido) pentanedioate (I) and its hydrates useful as active pharmaceutical ingredient in pharmaceutical compositions for the treatment of cancer. The present invention also relates to a process for preparation thereof.